Comment: A central issue in sleep medicine is the conflict between the risk of not sleeping, and the risk of taking sedative-hypnotics to help sleep. Most people assume medication induced sleep is better than not sleeping. This 15-year prospective data confirms that daily usage is associated with nearly three times the hazard of death compared […]
Comment: This was one of the earlier articles that really helped illustrate how important it is to keep the focus on absolute risk reduction to truly understand how effective an intervention is. Although this is a narrative review and has many risks of bias, other studies have borne out the concerns raised that the absolute […]
Comment: This is another in a growing group of studies showing a correlation between levothyroxine (synthetic T4) use and increased cancer risk. What makes this analysis particularly compelling is the direct comparison between treated and untreated patients with hypothyroidism. While we must respect the limitations of observational data, we must also be pragmatic: we are […]
Comment: A hazard ratio of 1.17 for all-cause mortality is a statistic that shouldn’t be ignored, but unfortunately is. It translates to 45 excess deaths for every 1,000 patients treated. But the most concerning aspect of this data is the graded relationship: the longer the exposure, the higher the risk of death. This dose-response curve […]
Comment: This is a fascinating review of a complex topic. The key clinical pearl here is the paradoxical finding that treatment-induced hypothyroidism (from TKIs/ICPis) often correlates with a favorable prognosis. It underscores the need to closely monitor thyroid function in these patients—not just as a side effect to be managed, but as a potential prognostic […]
Comment: While the finding that current MHT use is associated with concerning neuroimaging markers (accelerated Brain Age Gap, smaller hippocampus) compared to never-users warrants attention, there’s another important aspect – the lack of a statistically significant difference between specific formulations—namely oral versus non-oral (topical/vaginal) administration and estrogen-only versus combined HRT. It is becoming commonly accepted […]
Comment: This study is a classic example of one that is both exciting and deeply frustrating. The exciting part: A simple, cheap intervention (melatonin) was associated with a 70% relative reduction in death or heart failure readmission after a heart attack, supported by a significant, positive change in the MMP-9 biomarker. The frustrating part: The […]
Comment: Here we have another publication adding to the growing body of evidence supporting Natural Desiccated Thyroid (NDT) for the subset of patients who remain symptomatic on standard levothyroxine monotherapy. While this article is a “mini-review” and not a large-scale, rigorous RCT, it correctly highlights the crucial clinical reality: patient-reported outcomes and preferences matter. The […]
Comment: This is a powerful meta-analysis that validates what we and our patients have known for decades. The data is clear: patients overwhelmingly prefer combination therapy, and the network meta-analysis highlights that desiccated thyroid extract (DTE) is the most preferred intervention of all. What’s particularly telling is the discrepancy between patient preference and the results […]
Comment: This is a critical review that articulates a frustration many clinicians and patients have long experienced. It provide a strong physiological rationale for why the standard TSH-centric approach is insufficient for a significant portion of our patients. The central takeaway is the biochemical evidence: LT4 monotherapy, even when it normalizes TSH, often fails to […]
